Find a company
Search the SBRI Healthcare and NHS Cancer Programme Innovation Open call portfolio.
If you would like further information on any of the companies listed in the Directory please contact the SBRI Healthcare PMO by email sbri@lgcgroup.com or tel: +44 20 8843 8125.
We would be happy to make introductions to the companies or provide any further feedback you require.
At a glance
Directory search results
Medtechtomarket Consulting
| Project | A low-cost rapid test for diagnosing and stratifying risk of paracetamol overdose in emergency medicine |
|---|---|
| Funding | £ 78,931 |
| Competition | Competition 17 - Urgent and Emergency Care |
| Competition Date | October 2020 |
| Health Innovation Network Partner | North West Coast AHSN |
| Website | http://www.medtechtomarket.com/ |
Saccade Diagnostics Limited
| Project | SaccScan eye movement test for early detection of mental illnesses |
|---|---|
| Description |
Biomarkers have the potential to revolutionize the diagnosis and management of psychiatric disorders which affects 1 in 5 of us during our lifetime. The present symptom based diagnoses are unreliable with more than 50% of cases misdiagnosed at first presentation leading to suboptimal, inappropriate or even dangerous treatments. We have developed SaccScan - a Point-of-Care tool which has been demonstrated to detect schizophrenia and related illnesses with better than 95% accuracy. Early economic modelling showed that early detection of schizophrenia using SaccScan could produce savings of £33,474 per patient in the case of suspected schizophrenia alone. |
| Funding | £ 83,333 |
| Competition | Competition 12 - General Practice of the Future |
| Competition Date | November 2016 |
| Website | http://www.saccade-diagnostics.com/landing/ |
C the Signs Limited
| Project | C the Signs - Fighting Cancer with Early Diagnosis |
|---|---|
| Description |
By 2020 one in two people in the UK will be diagnosed with Cancer at some point in their life. Approximately 50% will be diagnosed late, with an associated 80% mortality. Our innovation, C the Signs, is a digital tool (App & website) that uses the latest evidence to help GPs identify patients with suspected Cancer early. Covering the entire spectrum of Cancer and cross-referencing multiple diagnostic pathways, C the Signs can support GPs in recommending what tests, investigations or referrals a patient may need in under 30 seconds. |
| Funding | £ 916,266 |
| Competition | Competition 13 - Cancer: screening, earlier and faster diagnosis |
| Competition Date | September 2017 |
| Categories | Cancer , Health inequalities |
| Health Innovation Network Partner | Eastern AHSN |
| Website | https://cthesigns.co.uk |